BACKGROUND:Low socioeconomic status is associated with worse secondary prevention use and prognosis after myocardial infarction (MI). Actions for health equity improvements warrant identification of risk mediators. Therefore, we assessed mediators of the association between socioeconomic status and first recurrent atherosclerotic cardiovascular disease event (rASCVD) after MI. METHODS:In this cohort study on 1-year survivors of first-ever MI with Swedish universal health coverage ages 18 to 76 years, individual-level data from SWEDEHEART (Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies) and linked national registries was collected from 2006 through 2020....
Socioeconomic status (SES) has a measurable and significant effect on cardiovascular health. Biologi...
Abstract Background Socioeconomic status (SES) predicts coronary heart disease independently of the ...
Despite improvements in the treatment of myocardial infarction (MI), risk-associated management disp...
BACKGROUND:Low socioeconomic status is associated with worse secondary prevention use and prognosis ...
Objective People's socioeconomic status (SES) has a major impact on the risk of atherosclerotic car...
BACKGROUND: Low socioeconomic status (SES) has been previously shown to be associated with worse car...
PURPOSE: To investigate the association between socioeconomic position and use of lipid-lowering dru...
Much remains to be understood about how low socioeconomic status (SES) increases cardiovascular dise...
Background: Mortality and morbidity are known to be negatively associated with socioeconomic status ...
OBJECTIVE: To examine the influence of socioeconomic deprivation on case fatality following acute my...
Background: Coronary heart disease (CHD) and myocardial infarction (MI) are associated with neighbor...
Background: Patients living under better socioeconomic circumstances often receive more active treat...
Previous studies have found that the socioeconomic risk factors education, income and family type we...
The health and economic burden of cardiovascular disease (CVD) is greater than that of any other dis...
Christina Boesgaard Graversen,1 Jan Brink Valentin,2 Mogens Lytken Larsen,3 Sam Riahi,1,3 Teresa Hol...
Socioeconomic status (SES) has a measurable and significant effect on cardiovascular health. Biologi...
Abstract Background Socioeconomic status (SES) predicts coronary heart disease independently of the ...
Despite improvements in the treatment of myocardial infarction (MI), risk-associated management disp...
BACKGROUND:Low socioeconomic status is associated with worse secondary prevention use and prognosis ...
Objective People's socioeconomic status (SES) has a major impact on the risk of atherosclerotic car...
BACKGROUND: Low socioeconomic status (SES) has been previously shown to be associated with worse car...
PURPOSE: To investigate the association between socioeconomic position and use of lipid-lowering dru...
Much remains to be understood about how low socioeconomic status (SES) increases cardiovascular dise...
Background: Mortality and morbidity are known to be negatively associated with socioeconomic status ...
OBJECTIVE: To examine the influence of socioeconomic deprivation on case fatality following acute my...
Background: Coronary heart disease (CHD) and myocardial infarction (MI) are associated with neighbor...
Background: Patients living under better socioeconomic circumstances often receive more active treat...
Previous studies have found that the socioeconomic risk factors education, income and family type we...
The health and economic burden of cardiovascular disease (CVD) is greater than that of any other dis...
Christina Boesgaard Graversen,1 Jan Brink Valentin,2 Mogens Lytken Larsen,3 Sam Riahi,1,3 Teresa Hol...
Socioeconomic status (SES) has a measurable and significant effect on cardiovascular health. Biologi...
Abstract Background Socioeconomic status (SES) predicts coronary heart disease independently of the ...
Despite improvements in the treatment of myocardial infarction (MI), risk-associated management disp...